(¿Â¶óÀÎ) Á¦34Â÷ Ãá°èÇмú´ëȸ ¹× Á¦5Â÷ ÇÑÀÏ´ç´¢º´Æ÷·³ : 2021-05-07±³À°ÀÏÀÚ : 2021-05-07
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) Á¦34Â÷ Ãá°èÇмú´ëȸ ¹× Á¦5Â÷ ÇÑÀÏ´ç´¢º´Æ÷·³ ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071
À̸ÞÀÏ :
diabetes@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 130,000¿ø
ºñ°í Àü¹®ÀÇ È¸¿ø 80,000¿ø Àü¹®ÀǺñȸ¿ø 130,000¿ø Àü¹®ÀÇ¿Ü È¸¿ø 50,000¿ø Àü¹®ÀÇ¿Ü ºñȸ¿ø 100,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 09:00~09:30 Advanced insulin delivery devices (insulin patch pump, digital insulin pen) ¹Úö¿µ(¼º±Õ°üÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 09:30~10:00 Application of CGM in inpatient setting including critical ill patients ÁøÈï¿ë(ÀüºÏÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 10:00~10:30 Efficacy of CGM for type 2 diabetes ·ùÇýÁø(°í´ëÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 10:30~11:00 Effect of the mobile phone-based systems for type 2 diabetes in primary care clinic settings ¾ç¿©¸®(°¡Å縯ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 11:50~12:30 Insulin resistance: from the mechanism to therapeutic targets ÃÖö¼ö(°¡ÃµÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 12:40~13:00 Role of SGLT2 inhibitor in cardio-renal continuum: what is the best time to take SGLT2i for T2D patients? È«ÁØÈ(À»ÁöÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 13:00~13:30 ´ç´¢º´ Ä¡·áÀÇ ½ÃÀÛ: Àν¶¸° °³¹ß À̾߱â À¯ÇüÁØ(CMº´¿ø)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 13:30~14:00 ´ç´¢º´ Ä¡·áÀÇ º¯È: Àν¶¸° ÀÌÈÄÀÇ º¯È ¿øÁ¾Ã¶(ÀÎÁ¦ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 14:00~14:30 Çѱ¹ÀÎ ´ç´¢º´ Ä¡·áÀÇ ÇöÀç¿Í ¹Ì·¡: ÇöȲ°ú °úÁ¦ ±è´ëÁß(¾ÆÁÖÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 15:30~16:00 Is albuminuria a therapeutic target for diabetic kidney disease? ¿À¼¼¿ø(°í·ÁÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 16:00~16:30 Glycemic control in patients with ESKD; should they be treated less intensively? ±è¹Ì°æ(°è¸íÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 16:30~17:00 Is protein restriction effective on all diabetic patients with CKD? À̼ö¹Ì(µ¿¾ÆÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 05-07 ¿Â¶óÀÎ 17:00~17:30 Is metformin bad for CKD in diabetic patients? ÀÌÁ¤Ç¥(¼¿ïÀÇ´ë ½ÅÀå³»°ú)